Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Allogeneic stem-cell transplantation for renal-cell cancer.

Gommersall L, Hayne D, Lynch C, Joseph JV, Arya M, Patel HR.

Lancet Oncol. 2004 Sep;5(9):561-7. Review.

PMID:
15337486
2.

Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.

Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, Read EJ, Tisdale J, Dunbar C, Linehan WM, Young NS, Barrett AJ.

N Engl J Med. 2000 Sep 14;343(11):750-8.

3.

Relationship between tumor-infiltrating T lymphocytes and clinical response after reduced-intensity allogeneic hematopoietic stem cell transplantation for advanced renal cell carcinoma: a single center prospective study.

Ishiyama K, Takami A, Suzuki S, Konaka H, Namiki M, Ooi A, Nakao S.

Jpn J Clin Oncol. 2009 Dec;39(12):807-12. doi: 10.1093/jjco/hyp104. Epub 2009 Sep 20.

PMID:
19770130
4.

Nonmyeloablative transplantation: an allogeneic-based immunotherapy for renal cell carcinoma.

Takahashi Y, Childs RW.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6353S-9S. Review.

5.
6.

Durable remission of renal cell carcinoma in conjuncture with graft versus host disease following allogeneic stem cell transplantation and donor lymphocyte infusion: rule or exception?

van Bergen CA, Verdegaal EM, Honders MW, Hoogstraten C, Steijn-van Tol AQ, de Quartel L, de Jong J, Meyering M, Falkenburg JH, Griffioen M, Osanto S.

PLoS One. 2014 Jan 15;9(1):e85198. doi: 10.1371/journal.pone.0085198. eCollection 2014.

7.

Nonmyeloablative stem cell transplantation in metastatic renal cell carcinoma: delayed graft-versus-tumor effect is associated with chimerism conversion but transplantation has high toxicity.

Massenkeil G, Roigas J, Nagy M, Wille A, Stroszczynski C, Mapara MY, Loening S, Dörken B, Arnold R.

Bone Marrow Transplant. 2004 Aug;34(4):309-16.

PMID:
15220955
8.

Allogeneic hematopoietic stem-cell transplantation: the next generation of therapy for metastatic renal cell cancer.

Arya M, Chao D, Patel HR.

Nat Clin Pract Oncol. 2004 Nov;1(1):32-8. Review.

PMID:
16264797
9.

Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.

Rini BI, Halabi S, Barrier R, Margolin KA, Avigan D, Logan T, Stadler WM, McCarthy PL, Linker CA, Small EJ; Cancer and Leukemia Group B; Eastern Cooperative Oncology Group; Southwestern Oncology Group.

Biol Blood Marrow Transplant. 2006 Jul;12(7):778-85.

10.

Allogeneic stem cell transplantation for renal cell carcinoma.

Childs R, Drachenberg D.

Curr Opin Urol. 2001 Sep;11(5):495-502. Review.

PMID:
11493771
11.

Allogeneic stem cell transplantation for renal cell carcinoma.

Bregni M, Herr W, Blaise D; Solid Tumor Working Party of EBMT.

Expert Rev Anticancer Ther. 2011 Jun;11(6):901-11. doi: 10.1586/era.11.12. Review.

PMID:
21707287
12.

[Allogeneic hematopoietic stem cell transplantation for solid tumors in the United States: a review].

Cheng YC, Ueno NT.

Nihon Rinsho. 2003 Sep;61(9):1619-34. Review. Japanese.

PMID:
14515734
13.

Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals.

Slavin S, Aker M, Shapira MY, Panigrahi S, Gabriel C, Or R.

Transfus Apher Sci. 2002 Oct;27(2):159-66. Review.

PMID:
12350051
14.

Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up.

Nakagawa T, Kami M, Hori A, Kim SW, Murashige N, Hamaki T, Kishi Y, Fujimoto H, Matsuoka N, Okajima E, Komiyama M, Tobisu K, Wakayama T, Uike N, Tajima K, Makimoto A, Mori S, Tanosaki R, Takaue Y, Kakizoe T.

Exp Hematol. 2004 Jul;32(7):599-606.

PMID:
15246155
15.

Nonmyeloablative allogeneic stem-cell transplantation for metastatic renal cell cancer: a review and update.

Erotocritou P, Ahmed H, Patel SS, Shergill I, Patel HR, Shah PM, Arya M.

ScientificWorldJournal. 2006 Dec 15;6:2519-28. Review.

16.
17.

Allogeneic stem-cell transplantation in renal-cell carcinoma.

Hayes-Lattin BM, Maziarz RT, Beer TM.

Curr Oncol Rep. 2001 Sep;3(5):433-7. Review.

PMID:
11489245
18.

Allogeneic stem cell transplantation as immunotherapy for nonhematological cancers.

Srinivasan R, Barrett J, Childs R.

Semin Oncol. 2004 Feb;31(1):47-55. Review.

PMID:
14970937
19.

Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma.

Yun T, Lee KW, Song EG, Na II, Shin HC, Yoon SS, Park SY, Kim BK, Lee JH, Choi SJ, Lee JH, Lee KH.

Clin Transplant. 2007 May-Jun;21(3):337-43.

PMID:
17488382
20.

Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.

Slavin S, Aker M, Shapira MY, Resnick I, Bitan M, Or R.

Clin Transpl. 2003:275-82. Review.

PMID:
15387119

Supplemental Content

Support Center